Description
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02017-04-01$3,997,503
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2017-04-01(start date) | $3,997,503 | — | Development of a safe, effective and clinically acceptable VSV-based HIV vaccine |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2020-2021-Q4-00026 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $44,460 | FY2021 |
| 236-2019-2020-Q4-00402 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $999,356 | FY2020 |
| 236-2016-2017-Q2-00212 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $1,400,000 | FY2017 |
| 236-2016-2017-Q2-00381 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $1,402,860 | FY2017 |
| 236-2015-2016-Q3-00074 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $229,250 | FY2016 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q1-00398 · retrieved 2026-11-13.